American Journal of Preventive Medicine , 42 (5), e57e64
The bilateral and symmetric nature of GSH reduction observed in our study is consistent with the bilateral involvement of the thalamus in migraine pathophysiology and suggests a systemic metabolic vulnerability rather than a lateralized structural abnormality
Whilst sweating is not listed as a common side effect in official prescribing information for GLP-1 medications such as semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), or liraglutide (Victoza, Saxenda), several indirect factors may explain this phenomenon
Food and Drug Administration have banned the sale of compounded weight loss drugs including Ozempic, Mounjaro, Wegovy and Zepbound
Retatrutide activates GLP-1, GIP, and glucagon receptors, while Semaglutide primarily activates the GLP-1 receptor pathway